FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Syndicate content

GSK gets Boostrix approval for adults over 65

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!


GlaxoSmithKline has gained FDA approval for its tetanus, diphtheria and whooping cough vaccine Boostrix in adults 65 and older. It's the first vaccine that protects older adults from all three diseases with a single shot. With the expanded indication, the vaccine can now be given to people over the age of 10.

"Although many people may have been vaccinated against whooping cough as children, immunity can wear off over time," explained GSK VP of Medical Affairs Leonard Friedland. "Adults, including those age 65 and older, should speak with their healthcare providers to make sure their vaccinations are up to date and to discuss the Centers for Disease Control and Prevention's recommendations for preventing tetanus, diphtheria and pertussis."

Whooping cough cases are on the rise due in part to some parents refusing to get their children vaccinated. Michigan, Ohio, New York and Pennsylvania have all reported a rise in cases of the disease, and California declared a whooping cough epidemic in 2010.

- here's GSK's release
- read more from UPI

Related Articles:
Expanded indication for GSK's Boostrix approved
Vaccination gaps contribute to pertussis outbreak

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about GlaxoSmithKline   Boostrix   whooping cough  


Post a comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

This question is for testing whether you are a human visitor and to prevent automated spam submissions.